Stock Expert AI

CGIC (CGIC) ETF Analysis

CGIC is an ETF providing exposure to a concentrated portfolio of international equities. With a portfolio of just 9 holdings, CGIC offers a focused approach to global investing.

The fund's top holdings include companies like Taiwan Semiconductor Manufacturing and ASML Holding. As of 2026-03-15, CGIC has a dividend yield of 0.00% and a beta of 0.00, indicating relatively low volatility compared to the broader market. Past performance does not guarantee future results.

CGIC (CGIC) ETF — Price, Holdings & Analysis

CGIC is an ETF providing exposure to a concentrated portfolio of international equities. With a portfolio of just 9 holdings, CGIC offers a focused approach to global investing. The fund's top holdings include companies like Taiwan Semiconductor Manufacturing and ASML Holding. As of 2026-03-15, CGIC has a dividend yield of 0.00% and a beta of 0.00, indicating relatively low volatility compared to the broader market. Past performance does not guarantee future results.

Descripción general del ETF

CGIC aims to provide investors with a concentrated portfolio of international stocks. The fund achieves this by investing in a small number of carefully selected companies. Its top holdings reflect a focus on technology and healthcare, with significant allocations to Taiwan Semiconductor Manufacturing Co Ltd ADR (5.19%), ASML Holding NV (2.30%), and Samsung Electronics Co Ltd (2.08%). Other notable holdings include AstraZeneca PLC (2.01%) and BAE Systems PLC (1.90%). This concentrated approach can lead to higher potential returns but also increased risk compared to more diversified international equity ETFs. The fund's strategy is suited for investors seeking targeted exposure to specific global companies and sectors, potentially as a complement to a broader, more diversified portfolio. Past performance does not guarantee future results.

Métricas de riesgo

CGIC's concentrated portfolio of just 9 holdings presents a significant concentration risk. A decline in the performance of even one of its top holdings, such as Taiwan Semiconductor Manufacturing (5.19%), could have a substantial negative impact on the fund's overall performance. The fund's sector allocation also contributes to its risk profile, with a notable emphasis on technology and healthcare companies. The ETF's beta of 0.00 suggests it has historically exhibited very low volatility relative to the market. Investors should also consider the impact of the fund's expense ratio on overall returns, although a specific expense ratio is not provided in the data. Past performance does not guarantee future results.

¿Qué contiene CGIC?

ParticipaciónPeso
Taiwan Semiconductor Manufacturing Co Ltd ADR (TSM)5.19%
ASML Holding NV (ASML.AS)2.30%
Samsung Electronics Co Ltd (005930.KS)2.08%
AstraZeneca PLC (AZN.L)2.01%
BAE Systems PLC (BA.L)1.90%
British American Tobacco PLC (BATS.L)1.50%
TotalEnergies SE (TTE.PA)1.46%
UniCredit SpA (UCG.MI)1.36%
Koninklijke KPN NV (KPN.AS)1.33%

Rentabilidad por dividendo

0.00%

Métricas de riesgo

  • Beta: 0.00

Preguntas y respuestas

What is CGIC and what does it track?

CGIC is an ETF that provides investors with exposure to a concentrated portfolio of international equities. Unlike broad-based international ETFs, CGIC invests in a very limited number of companies, with only 9 holdings.

This focused approach allows investors to target specific global companies and sectors.

What is the expense ratio for CGIC?

The provided data does not include the expense ratio for CGIC. When evaluating ETFs, the expense ratio is a critical factor to consider, as it directly impacts the fund's net returns.

It's important to compare the ETF's expense ratio to similar ETFs in the international equity category.

What are the top holdings in CGIC?

CGIC's top holdings are concentrated in a small number of international companies.

As of 2026-03-15, the top three holdings are Taiwan Semiconductor Manufacturing Co Ltd ADR (TSM) at 5.19%, ASML Holding NV (ASML.AS) at 2.30%, and Samsung Electronics Co Ltd (005930.KS) at 2.08%. Other significant holdings include AstraZeneca PLC (AZN.L) at 2.01% and BAE Systems PLC (BA.L) at 1.90%.

Is CGIC a good long-term investment?

Whether CGIC is a suitable long-term investment depends on an investor's individual risk tolerance and investment objectives. The fund's concentrated portfolio of just 9 holdings presents both opportunities and risks.

The potential for higher returns exists if the fund's top holdings perform well, but the concentration also increases the risk of significant losses if those companies underperform.

How does CGIC compare to similar ETFs?

CGIC distinguishes itself from similar international equity ETFs through its highly concentrated portfolio. While many international ETFs hold hundreds or even thousands of stocks to achieve broad diversification, CGIC invests in only 9 companies.

This concentrated approach can lead to different performance outcomes compared to more diversified ETFs. Without expense ratio or AUM data, a full comparison is not possible.

Does CGIC pay dividends?

As of 2026-03-15, CGIC has a dividend yield of 0.00%. This indicates that the fund is not currently distributing any dividend income to its shareholders.

Investors seeking income from their investments may want to consider other ETFs with higher dividend yields. However, it's important to note that dividend yields can fluctuate over time and are not guaranteed. Past performance does not guarantee future results.